Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More


Learn what's happening in the world of Dohmen and our clients
September 13, 2017

Dohmen releases new white paper on how better patient understanding leads to improved outcomes

New insights from clinical care experts and patient advocacy organizations call attention to the importance of understanding the unknown and unmet needs of the patient journey.
learn more
September 12, 2017

Dohmen proudly supports upcoming Global Genes 2017 Rare Patient Advocacy Summit

Rare diseases affect 1 in 10 Americans - that’s roughly 30 million people. Every day Dohmen Life Science Services (DLSS) aims to reduce the burden of disease by offering patient services and support on behalf of orphan drug manufacturers.
learn more
September 05, 2017

Dohmen experts shine light on urgent regulatory & financial issues at upcoming MDRP Summit

The Dohmen Life Science Services (DLSS) Market Access and Government Programs team will take center stage at the upcoming Medicaid Drug Rebate (MDRP) Summit, September 11-13 in Chicago.
learn more
July 28, 2017

Dohmen Life Science Services showcases the value of integrated outsourcing at upcoming NACDS Expo

Dohmen Life Science Services (DLSS) experts will join fellow industry leaders at the upcoming National Association of Chain Drug Stores (NACDS) Total Store Expo, Aug. 19-22, in San Diego.
learn more
July 20, 2017

Dohmen leads keynote panel at Patient Support Services and HUB Design Summit, July 24-25

Patients are empowered like never before. This summit brings together orphan drug manufacturers, BPOs, doctors and researchers to build better awareness and understanding of patients’ needs.
learn more
June 21, 2017

Dohmen proudly sponsors the 26th Alpha-1 National Education Conference, June 23-25

The Dohmen Life Science Services (DLSS) team will join hundreds of rare disease experts, patients and caregivers at the 26th Alpha-1 National Education Conference in Chicago, IL.
learn more
June 16, 2017

Dohmen welcomes Lynda Parker, Chief Business Development Officer, Direct-to-Patient Services, DLSS

With more than 30 years of experience, Linda has successfully led product commercialization and helped orphan drug manufacturers overcome the challenges faced in serving and providing ongoing support to the rare disease community.
learn more
June 08, 2017

Dohmen celebrates with NORD Rare Impact Award Winners

The Dohmen team recently joined more than 400 people at the National Organization for Rare Disorders (NORD) 2017 Impact Awards ceremony in Washington, D.C. The inspiring evening celebrated individuals and organizations who are making extraordinary contributions to the rare disease community.
learn more